Перспективы локального применения антирезорбтивных препаратов при повреждениях и заболеваниях костей скелета
- Авторы: Родионова С.С.1, Лекишвили М.В1, Склянчук Е.Д2, Торгашин А.Н1, Рябов А.Ю3, Юрасова Ю.Б4
-
Учреждения:
- ФГБУ «Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова» Минздрава России, Москва
- Московский государственный медико-стоматологический университет, Москва
- стоматологический центр «Интердентос», Королев
- Российская детская клиническая больница, Москва, РФ
- Выпуск: Том 21, № 4 (2014)
- Страницы: 83-89
- Раздел: Статьи
- URL: https://journals.rcsi.science/0869-8678/article/view/47637
- DOI: https://doi.org/10.17816/vto20140483-89
- ID: 47637
Цитировать
Полный текст
Аннотация
Ключевые слова
Об авторах
Светлана Семеновна Родионова
ФГБУ «Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова» Минздрава России, Москва
Email: rod06@inbox.ru
доктор мед. наук, профессор , рук. научно-клинического центра остеопороза ЦИТО; Тел.: 8 (495) 601-44-07. 127299, Москва, ул. Приорова, д. 10, научно-клинический центр остеопороза ЦИТО им. Н.Н. Приорова
М. В Лекишвили
ФГБУ «Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова» Минздрава России, Москвадоктор мед. наук, зав. лабораторией «Тканевой банк» ЦИТО
Е. Д Склянчук
Московский государственный медико-стоматологический университет, Москвадоктор мед. наук, проф. кафедры травматологии и ортопедии МГМСУ
А. Н Торгашин
ФГБУ «Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н. Приорова» Минздрава России, Москваканд. мед. наук, науч. сотр., научно-клинического центра остеопороза ЦИТО
А. Ю Рябов
стоматологический центр «Интердентос», Королевканд. мед. наук, СЦ « Интердентос»
Ю. Б Юрасова
Российская детская клиническая больница, Москва, РФдоктор мед. наук, зав. отделением нефрологии РДКБ.
Список литературы
- Shanbhag A.S. Use of bisphosphonates to improve the durability of total joint replacements. J. Am Academy Orthop. Surg. 2006; 14 (4): 215-25.
- Astrand J., Aspenberg P. Alendronate did not inhibit instability-induced bone resorption. A study in rats. Acta Orthop. Scand. 1999; 70 (1): 67-70.
- Bauer T.W., Smith S.T. Bioactive materials in orthopaedic surgery: overview and regulatory considerations. Clin. Orthop. Relat. Res. 2002; 395: 11-22.
- Kanis J.A., Adams J., Borgström F., Cooper C., Jönsson B., Preedy D. et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone. 2008; 42 (1): 4-15.
- Svedbom A., Hernlund E., Ivergård M., Compston J., Cooper C., Stenmark J. et al. Osteoporosis in the European Union: a compendium of country-specific reports Osteoporosis in the European Union: a compendium of country-specific reports. Arch. Osteoporos. 2013; 8 (1-2): 137.
- Plotkin L.I., Lezcano V., Thostenson J., Weinstein R.S., Manolagas S.C., Bellido T. Connexin Is Required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J. Bone Miner Res. 2008; 23 (11): 1712-21.
- Chapurlat R.D., Arlot M., Burt-Pichat B. Chavassieux P., Roux J.P., Portero-Muzy N. et al. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study. J. Bone Miner. Res. 2008; 23 (7): 1150-1.
- Cranney А., Wells G., Willan A. et al. The osteoporosis methodology group and the osteoporosis research advisory group. Meta-analysis of alendronate for the treatment of postmenopausal women: ten years experience with alendronate for osteoporosis in postmenopausal women. Endocrine Reviews. 2002; 23 (4): 508-16.
- Matuszewski Ł., Turżańska K., Matuszewska A. Jabłoński M., Polkowska I., Mazurkiewicz T. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. Int Orthop. (SICOT). 2013; 37: 1187-93.
- Faucheux C., Verron E., Soueidan A., Josse S., Arshad M.D., Janvier P. et al. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro. J. Biomed. Mater. Res. A. 2009; 89 (1): 46-56.
- Russell R.G.G., Watts N.B., Ebetino F.H., Rogers M.J. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporosis Int. 2008; 19 (6): 733-59.
- Fleisch H. Mechanisms of action of the bisphosphonates. Medicina (B Aires). 1997; 57 (Suppl 1): 65-75.
- Greiner S.H., Kadow-Romacker A., Lubberstedt M. Schmidmaier G., Wildemann B. The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro J. Biomed Mater. Res. A. 2006; 80 (4): 769-75.
- Millett P.J., Allen M.J., Bostrom M.P. Effects of alendronate on particle-induced osteolysis in a rat model. J. Bone Joint Surg. Am. 2002; 84 (2): 236-49.
- Stadelmann V.A., Terrier A., Gauthier O. Bouler J.M., Pioletti D.P. Prediction of bone density around orthopedic implants delivering bisphosphonate. J. Biomechanics. 2009; 42 (9): 1206-11.
- Bone H.G., Hosking D., Devogelaer J., Tucci J.R., Emkey R.D., Tonino R.P. et al. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N. Engl. J. Med. 2004; 350: 1189-99.
- Hu J.U., Ding M., Soballe K., Bechtokd J.E., Danielsen C.C., Day J.S. et al. Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone. Bone. 2002; 31 (5): 591-7.
- Arabmotlagh M., Rittmeister M., Hcnnigs T. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J. Orthop. Res. 2006; 24 (7): 1336-41.
- Родионова С.С., Тургумбаев Т.Н. Применение алендроната в послеоперационном периоде для профилактики асептической нестабильности эндопротеза тазобедренного сустава. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2009; 3: 36-44.
- Bhandari M., Bajammal S., Guyatt G.H. Griffith L, Busse JW, Schünemann H,et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J. Bone Joint Surg. Am. 2005; 87 (2): 293-301.
- Chacon G.E., Stine E.A., Larsen P.E. Beck F.M., McGlumphy E.A. Effect of alendronate on endosseous implant integration: an in vivo study in rabbits. J. Oral Maxillofac. Surg. 2006; 64 (7): 1005-9.
- Astrand J., Aspenberg P. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats. Acta Orthop. Scand. 2002; 73: 24-30.
- Aspenberg P., Herbertsson P. Periprosthelic bone resorption. Particles versus movement. J. Bone Joint Surg. Br. 1996; 78 (4): 641-6.
- Gut G., Sladowski D. Mechanical properties of bone fixation devices prepared from a human allogenic bone. Transplant Proc. 2007; 39 (9): 2920-2.
- Faucheux C., Verron E., Soueidan A., Josse S., Arshad M.D., Janvier P. et al. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro. J. Biomed. Mater. Res. 2009; 1: 46-56.
- Greiner S.H., Kadow-Romacker A., Wildemann B. Schwabe P., Schmidmaier G. Bisphosphonates incorporated in a poly(D,L-lactide) implant coating inhibit osteoblast like cells in vitro. J. Biomed Mater. Res. 2007; 83 (4): 1184-91.
- Aspenberg P., Astrand J. Bone allografts pretreated with a bisphosphonate are not resorbed. Acta Orthop. Scand. 2002; 73 (1): 20-3.
- Astrand J., Aspenberg P. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening. J. Orthop. Res. 2004; 22 (2): 244-9.
- Gao Y., Zou S., Liu X., Bao C., Hu J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009; 30 (9): 1790-6.
- Greiner S.H., Wildemann B., Back D.A., Alidoust M., Schwabe P., Haas N.P. et al. Local application of zoledronic acid incorporated in a poly (D,L-lactide) coated implant accelerates fracture healing in rats. Acta Orthop. 2008; 79 (5): 717-25.
- Bobyn J.D., Hacking S.A., Krygier J.J., Harvey E.J., Little D.G., Tanzer M. Zoledronic acid causes enhancement of bone growth into porous implants. J. Bone Joint Surg. Br. 2005; 87 (3): 416-20.
- Ding M., Day J.S., Burr D.B. Mashiba T., Hirano T., Weinans H. et al. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. Calcified Tissue Int. 2003; 72 (6): 737-44.
- Jakobsen T., Kold S., Bechtold J.E., Elmengaard B., Søballe K. Effect of topical alendronate treatment on fixation of implants inserted with bone compaction. Clin Orthop. Relat. Res. 2006; 444: 229-34.
- Jakobsen T., Baas J., Bechtold J.E., Elmengaard B., Søballe K. Soaking morselized allograft in bisphosphonate can impair implant fixation. Clin. Orthop. Relat. Res. 2007; 463: 195-201.
- Jakobsen T., Kold S., Bechtold J.E., Elmengaard B., Søballe K. Local alendronate increases fixation of implants inserted with bone compaction: 12-week canine study. J. Orthop. Res. 2007; 25 (4): 432-41.
- Jakobsen T., Baas J., Bechtold J.E., Elmengaard B., Søballe K. The effect of soaking allograft in bisphosphonate. Clin Orthop. Relat. Res. 2010; 468: 867-74.
- Jakobsen T., Baas J., Bechtold J.E., Elmengaard B., Søballe K. The effect on implant fixation of soaking tricalcium phosphate granules in bisphosphonate. Open Orthop. J. 2012; 6: 371-5.
- Søballe K., Chen X., Jensen T.B. Kidder L., Bechtold J.E. Alendronate treatment in the revision setting, with and without controlled implant motion: an experimental study in dogs. Acta Orthop. 2007; 78 (6): 800-7.
- Tanzer M., Karabasz D., Krygier J.J. Cohen R., Bobyn J.D. Bone augmentation around and within porous implants by local bisphosphonate elution. Clin. Orthop. Relat. Res. 2005; 441: 30-9.
- DiResta G.R., Manoso M,W., Naqvi A., Zanzonico P., Smith-Jones P., Tyler W. et al. Bisphosphonate delivery to tubular bone allografts. Clin Orthop. Relat. Res. 2008; 466: 1871-9.
- Xue Q., Li H., Zou X., Bünger M., Egund N., Lind M. et al. Healing properties of allograft from alendronate-treated animal in lumbar spine interbody cage fusion. Eur. Spine J. 2005; 14 (3): 222-6.
- Jakobsen T., Baas J., Kold S., Bechtold J.E., Elmengaard B., Søballe K. Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction. J. Orthop. Res. 2009; 27 (2): 189-94.
- Abtahi J., Agholme F., Sandberg O., Aspenberg P. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw. J. Dental Research. 2013; 92 (3): 279-83.
- Millett P.J., Allen M.J., Bostrom M.P. Effects of alendronate on particle-induced osteolysis in a rat model. J. Bone Joint Surg. Am. 2002; 84 (2): 236-49.
- Åberg J., Brohede U., Mihranyan A. et al. Targeted local delivery of bisphosphonate from orthopaedic implants. Key Engineering Materials. 2008; Bioceramics 21: 543-46.
- Åberg J., Brohede U., Mihranyan A., Strømme M., Engqvist H. Bisphosphonate incorporation in surgical implant coatings by fast loading and co-precipitation at low drug concentrations. J. Mater Sci Mater. Med. 2009; 20 (10): 2053-61.
- Meraw S.J., Reeve C.M., Wollan P.C. Use of alendronate in peri-implant defect regeneration. J. Periodontol. 1999; 70 (2): 151-8.
- Ozturk A.M., Tabak A.Y., Aktekin C.N., Altay M., Erdemli E., Karahuseyinoglu S. et al. Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis. Int. Orthop. 2008; 32 (6): 821-7.
- McKenzie K., Dennis Bobyn J., Roberts J., Karabasz D., Tanzer M. Bisphosphonate remains highly localized after elution from porous implants. Clin. Orthop. Relat. Res. 2011; 469 (2): 514-22.
- Родионова С.С., Еловой-Вронский А.А. Связь эффективности комбинированного использования ибандроновой кислоты и альфакальцидола с ремоделированием костной ткани у женщин с постменопаузальной формой остеопороза. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2011; 4: 45-9.
- Back D.A., Pauly S., Romme L. Haas N.P., Schmidmaier G., Wildemann B. et al. Effect of local zoledronate on implant osseointegration in a rat model. BMC Musculoskelet. Disord. 2012; 13: 42.
- Gao Y., Zou S., Liu X., Bao C., Hu J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009; 30 (9): 1790-6.
- Agholme F., Aspenberg P. Experimental results of combining bisphosphonates with allograft in a rat model. J. Bone Joint Surg. Br. 2009; 91 (5): 670-5.
- Gangoiti M.V., Cortizo A.M., Arnol V. Felice J.I., McCarthy A.D. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells. Eur J. Pharmacol. 2008; 600 (1-3): 140-7.
- Stadelmann V.A., Terrier A., Gauthier O., Bouler J.M., Pioletti D.P. Prediction of bone density around orthopedic implants delivering bisphosphonate. J. Biomechanics. 2009; 42 (9): 1206-11.
- Родионова С.С., Торгашин А.Н., Лекишвили М.В., Семенова Л.А., Морозов А.К. Влияние бисфосфонатов в составе биокомпозиционного материала на костеобразование и минерализацию кости. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2011; 2: 59-66.
- Matos М.А., Tannuri U., Guarniero R. The effect of zoledronate during bone healing. J. Orthopaed Traumatol. 2010; 11: 7-12.
- Nancollas G.H., Tang R., Phipps R.J. Henneman Z., Gulde S., Wu W. et al. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone. 2006; 38 (5): 617-27.